InflaRx Appoints Jan Medina as Head of Investor Relations
February 22, 2024 07:30 ET
|
InflaRx N.V.
JENA, Germany, Feb. 22, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...